Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

R&D to Revenue

446.59%

Quarterly · Period ending: Jun 30, 2026

LCTX R&D to Revenue

Latest reported446.59%period endingJun 30, 2026

LCTX Quarterly R&D/Revenue (0.00% → 446.59%)

Latest values, visible window

High-resolution chart · PNG

LCTX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock R&D to Revenue — Quarterly
Period ending	R&D to Revenue
Jun 30, 2026	446.5856%
Mar 31, 2026	245.4493%
Dec 31, 2025	124.6671%
Sep 30, 2025	88.8617%
Jun 30, 2025	112.3327%
Mar 31, 2025	207.3236%
Dec 31, 2024	119.3515%
Sep 30, 2024	83.9111%
Jun 30, 2024	203.6932%
Mar 31, 2024	206.9252%
Dec 31, 2023	185.5364%
Sep 30, 2023	300.2408%
Jun 30, 2023	120.093%
Mar 31, 2023	175.3982%
Dec 31, 2022	214.3081%
Sep 30, 2022	119.8132%
Jun 30, 2022	72.5236%
Mar 31, 2022	57.0556%
Dec 31, 2021	2,581.0417%
Sep 30, 2021	127.6567%
Jun 30, 2021	664.6259%
Mar 31, 2021	1,158.3618%
Dec 31, 2020	1,570.4819%
Sep 30, 2020	1,042.6901%
Jun 30, 2020	2,833.3333%
Mar 31, 2020	2,011.4458%
Dec 31, 2019	418.9904%
Sep 30, 2019	1,965.8986%
Jun 30, 2019	2,094%
Mar 31, 2019	2,771.5084%
Dec 31, 2018	2,210.5263%
Sep 30, 2018	1,849.2424%
Jun 30, 2018	1,049.1749%
Mar 31, 2018	1,582.6667%
Dec 31, 2017	825.4833%
Sep 30, 2017	1,417.2786%
Jun 30, 2017	1,645.9318%
Mar 31, 2017	1,713.4565%
Dec 31, 2016	925.1979%
Sep 30, 2016	1,646.6667%
Jun 30, 2016	1,766.4032%
Mar 31, 2016	2,343.686%
Dec 31, 2015	2,304.1441%
Sep 30, 2015	1,361.0714%
Jun 30, 2015	1,583.7413%
Mar 31, 2015	1,648.3845%
Dec 31, 2014	2,538.7561%
Sep 30, 2014	1,625.7529%
Jun 30, 2014	1,945.9607%
Mar 31, 2014	1,711.9763%
Dec 31, 2013	731.5254%
Sep 30, 2013	1,163.4937%
Jun 30, 2013	1,057.7504%
Mar 31, 2013	1,029.3845%
Dec 31, 2012	925.0486%
Sep 30, 2012	452.9386%
Jun 30, 2012	446.5122%
Mar 31, 2012	661.256%
Dec 31, 2011	253.0303%
Sep 30, 2011	301.4475%
Jun 30, 2011	434.8187%
Mar 31, 2011	346.2974%
Dec 31, 2010	246.3072%
Sep 30, 2010	221.807%
Jun 30, 2010	210.0651%
Mar 31, 2010	151.2072%
Dec 31, 2009	141.3733%
Sep 30, 2009	166.4905%
Jun 30, 2009	148.0233%
Mar 31, 2009	177.1985%
Dec 31, 2008	137.9722%
Sep 30, 2008	128.4699%
Jun 30, 2008	101.5625%
Mar 31, 2008	91.1114%
Dec 31, 2007	67.8241%
Sep 30, 2007	73.7077%
Jun 30, 2007	100.0123%
Mar 31, 2007	139.8261%
Dec 31, 2006	97.46%
Sep 30, 2006	102.5475%
Jun 30, 2006	266.7663%
Mar 31, 2006	110.0065%
Dec 31, 2005	144.065%
Sep 30, 2005	166.843%
Jun 30, 2005	137.0019%
Mar 31, 2005	242.0979%
Dec 31, 2004	162.9942%
Sep 30, 2004	179.378%
Jun 30, 2004	141.7791%
Mar 31, 2004	174.2969%
Dec 31, 2003	89.9%
Sep 30, 2003	218.2215%
Jun 30, 2003	217.4826%
Mar 31, 2003	232.386%
Dec 31, 2002	135.1237%
Sep 30, 2002	293.5522%
Jun 30, 2002	564.8112%
Mar 31, 2002	455.2651%
Dec 31, 2001	575.3898%
Sep 30, 2001	649.3876%